(Q28193960)

4

0 references

Alistair Scott Hall

Alistair Hall

6

0 references

Lars Køber

5

Lars Kober

0 references

Salim Yusuf

2

Salim Yusuf

0 references

Janice Pogue

7

Janice Pogue

0 references

author name string

Koon K Teo

1

0 references

Marc Pfeffer

3

0 references

Roberto Latini

8

0 references

Rory Collins

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection

9

0 references

language of work or name

English

0 references

publication date

5 October 2002

0 references

published in

The Lancet

0 references

volume

360

0 references

issue

9339

0 references

page(s)

1037-43

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911138-X

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911138-X

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911138-X

7 January 2021

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911138-X

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911138-X

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911138-X

7 January 2021

Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911138-X

7 January 2021

Non-steroidal anti-inflammatory drugs and angiotensin converting enzyme inhibitors: a commonly prescribed combination with variable effects on renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911138-X

7 January 2021

Nonsteroidal antiinflammatory drugs--differences and similarities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911138-X

7 January 2021

Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911138-X

7 January 2021

Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: results of a double-blind, randomized comparative trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911138-X

7 January 2021

Combining salicylate and enalapril in patients with coronary artery disease and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911138-X

7 January 2021

Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911138-X

7 January 2021

Effects of Aspirin on Angiotensin-Converting Enzyme Inhibition and Left Ventricular Dilation One Year After Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911138-X

7 January 2021

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-conve

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911138-X

7 January 2021

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911138-X

7 January 2021

Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911138-X

7 January 2021

Why do we need some large, simple randomized trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911138-X

7 January 2021

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911138-X

7 January 2021